NeuroBionics

Funding and NIH signals

• SEC Form D raise Raised $4.25M (Form D filed Dec 10, 2025). SEC Form D 0002100415-25-000001 (Dec 10, 2025)
  Evidence (1 event)

  • Dec 10, 2025 · SEC Form D 0002100415-25-000001
    Name of Issuer: NeuroBionics Inc.; CIK: 2100415; Address: Somerville, MA; Submission type: D; Filing date: 2025-12-10; Industry Group: Other Technology; Date of First Sale: 2025-11-25; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4249990; Total Amount Sold: 4249990; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

• Raise Seed · $10M · announced Dec 16, 2025 Company release ↗
  Source quote

  • Dec 16, 2025 · Company release ↗
    “NeuroBionics Announces Oversubscribed $10M Seed Round with Second Close Led by Future Ventures”
• Raise Seed · $5M · announced Jan 21, 2025 Company release ↗
  Source quote

  • Jan 21, 2025 · Company release ↗
    “by NeuroBionics | Jan 21, 2025 | News , Press NeuroBionics , a neurotech company revolutionizing neuromodulation therapy with minimally invasive implantable devices, today announced the successful close of its $5 million Seed Round”
  • Dec 16, 2025 · Company release ↗
    “NeuroBionics Announces Oversubscribed $10M Seed Round with Second Close Led by Future Ventures”

Raises announced in these releases: $25M disclosed.

From the company’s own releases; this list is partial. All raises and deals